PS
TNDM icon

Principal Securities’s Tandem Diabetes Care TNDM Stock Holding History

Principal Securities’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-381
Closed -$4.63K – 3321
2025
Q3 		$4.63K Sell
381
-55
-13% -$744 ﹤0.01% 2989
2025
Q2 		$8.13K Buy
436
+215
+97% +$4.26K ﹤0.01% 2700
2025
Q1 		$7.96K Hold
221
– – ﹤0.01% 2613
2024
Q4 		$7.96K Sell
221
-60
-21% -$2.03K ﹤0.01% 2609
2024
Q3 		$11.9K Hold
281
– – ﹤0.01% 2357
2024
Q2 		$11.3K Sell
281
-5
-2% -$209 ﹤0.01% 2332
2024
Q1 		$10.1K Sell
286
-31
-10% -$831 ﹤0.01% 2329
2023
Q4 		$9.38K Buy
+317
New +$6.58K ﹤0.01% 2277

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Principal Securities's TNDM Position: Q4 2025 in Review

Principal Securities sold out of Tandem Diabetes Care (TNDM) in Q4 2025, closing a stake of 381 shares — an estimated $4.63K sold.

Principal Securities first reported a position in TNDM in Q4 2023 and held it in 8 quarters. The position peaked at $11.9K in Q3 2024. 268 funds tracked by Wall St. Rank hold TNDM as of Q4 2025.

  • Principal Securities reported no remaining Tandem Diabetes Care position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 381 Tandem Diabetes Care shares in Q4 2025, an estimated $4.63K.
  • Principal Securities first reported a position in Tandem Diabetes Care in Q4 2023 and held it in 8 quarters.
  • Principal Securities's Tandem Diabetes Care position peaked at $11.9K in Q3 2024.
  • 268 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.